Follow The Filings

RLAY Relay Therapeutics

Relay Therapeutics earnings company data as of 7:50 PM ET 10/23

Limited consensus data for this ticker (thin coverage or data-plan limits). Dates may be company-announced rather than sell-side consensus. Calendar and recent prints remain the primary lens when available.

Scheduled

1 period, newest first, nothing reported yet. Each row shows EPS above revenue.

Period Date Metric Estimate Actual Result
FY2026 Q3 5 Nov EPS — — —
Rev — — —

Insider trades

Open-market buys and sales by RLAY's executives, directors and 10% owners in the last 12 months, from their Form 4s

All RLAY insider trades
  • None no insider bought on the open market
  • $117M sold by 2 insiders outside a trading plan
  • $11.8M sold by 4 insiders under 10b5-1 plans
  1. Sanjiv Patel CEO
    Planned sale
    $872K 48,199 shares at $18.10 9.3% of stake
    Traded Oct 7 Filed Oct 8
    ↗
  2. Thomas Catinazzo CFO
    Planned sale
    $329K 17,717 shares at $18.59 14% of stake
    Traded Oct 6 Filed Oct 8
    ↗
  3. Donald A Bergstrom President, R&D
    Planned sale
    $162K 8,530 shares at $18.97 2.1% of stake
    Traded Sep 8 Filed Sep 9
    ↗
  4. Thomas Catinazzo CFO
    Planned sale
    $336K 17,717 shares at $18.94 13% of stake
    Traded Sep 8 Filed Sep 9
    ↗
  5. Sanjiv Patel CEO
    Planned sale
    $913K 48,199 shares at $18.94 8.5% of stake
    Traded Sep 8 Filed Sep 9
    ↗
  6. SVF Pauling (Cayman) Ltd 10% owner, +2 joint filers
    Sale
    $116M 6,000,000 shares at $19.40 22% of stake
    Traded Aug 25 Filed Aug 28
    ↗
  7. Peter Rahmer See remarks
    Planned sale
    $90K 4,508 shares at $20.03 2% of stake
    Traded Aug 26 Filed Aug 28
    ↗
  8. Sanjiv Patel CEO
    Planned sale
    $980K 48,199 shares at $20.33 7.8% of stake
    Traded Aug 17 Filed Aug 18
    ↗
  9. Thomas Catinazzo CFO
    Planned sale
    $350K 17,717 shares at $19.74 11% of stake
    Traded Aug 14 Filed Aug 18
    ↗
  10. Donald A Bergstrom President, R&D
    Planned sale
    $162K 8,660 shares at $18.71 2.1% of stake
    Traded Jul 6 Filed Jul 8
    ↗
  11. Sanjiv Patel CEO
    Planned sale
    $944K 48,199 shares at $19.58 7.3% of stake
    Traded Jul 7 Filed Jul 8
    ↗
  12. Thomas Catinazzo CFO
    Planned sale
    $331K 17,717 shares at $18.69 10% of stake
    Traded Jul 6 Filed Jul 8
    ↗
  13. Peter Rahmer See remarks
    Planned sale
    $955K 50,000 shares at $19.09 18% of stake
    Traded Jun 30 Filed Jul 2
    ↗
  14. Thomas Catinazzo CFO
    Planned sale
    $3.2M 187,163 shares at $16.97 51% of stake
    Traded Jun 22 Filed Jun 24
    ↗
  15. Donald A Bergstrom President, R&D
    Planned sale
    $1.6M 93,456 shares at $16.94 18% of stake
    Traded Jun 22 Filed Jun 24
    ↗

Also filed in the last 12 months, not counted as buying or selling: 17 sales to cover taxes, 5 option exercises, and 4 stock grants.

SEC filings

Recent issuer filings from EDGAR, 14 shown.

Filed Form Detail Links
SCHEDULE 13G/A — Filing Doc
SCHEDULE 13G/A — Filing Doc
SCHEDULE 13G/A — Filing Doc
SCHEDULE 13G — Filing Doc
8-K 1.01,2.02,9.01 Filing Doc
10-Q Filing Doc
424B5 Filing Doc
8-K 5.03,5.07,9.01 Filing Doc
424B5 Filing Doc
8-K 1.01,9.01 Filing Doc
8-K 7.01,8.01,9.01 Filing Doc
424B5 Filing Doc
SCHEDULE 13G/A — Filing Doc
10-Q Filing Doc

Source: SEC EDGAR submissions, updated 6 days ago. All on EDGAR

Estimates are consensus figures; SEC filings remain the official record. Not investment advice.